Dal Alert!

Receive alerts from Dalhousie by text message.

X

Bernhard Pohlmann-EdenMD, PhD

Professor

profile-PohlmannEden-2017-210x214px

Personal logo

pohlmann-eden-logo-277x153px

  

Division of Neurology , Department of Medicine

Email: b.pohlmann-eden@dal.ca
Research Topics:
  • development & improvement of health care structures (national and international)
  • quality of health care: management, prevention and safety
  • innovative drug trial designs
  • brain diseases as network disorders
  • clinical epileptogenesis with focus on first seizure populations
  • aging and epilepsy
  • mechanism of disease chronicity with focus on pharmacoresistance in epilepsy
  • knowledge transfer to patients and caregivers

Primary location: Toronto, ON

Education

  • PhD University of Heidelberg, Germany
  • MD University of Heidelberg, Germany
  • Visiting scientist, Massachusetts General Hospital, Harvard Medical School, Boston, USA
  • Visiting scientist, Krembil Neuroscience Center, University of Toronto, Canada

Selected publications

  • Pohlmann-Eden B, Aldenkamp A, Baker GA, Brandt C, Cendes F, Coras L, Crocker C, Helmstaedter C, Jones-Gotman M, Kanner AM, Mazarati A, Mula M, Smith ML, Omisade A, Tellez-Centeno J, Hermann B. The Relevance of Neuropsychiatric Symptoms and Cognitive Problems in New-onset Epilepsy – Current knowledge and understanding. Epilepsy & Behavior 51 (2015) 199–209. PMID: 26291774
  • Russell LA, Abbass AA, Allder SJ, Kisely S, Pohlmann-Eden B, Town JM. A pilot study of reduction in healthcare costs following the application of intensive short-term dynamic psychotherapy for psychogenic nonepileptic seizures. Epilepsy Behav. 2016 Aug 16;63:17-19. doi: 10.1016/j.yebeh.2016.07.017. PMID: 27541836
  • Pohlmann-Eden B, Marson AG, Noack-Rink M, Ramirez F, Tofighy A, Werhahn KJ, Wild I, Trinka E. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study. BMC Neurol. 2016 Aug 23;16(1):149. doi: 10.1186/s12883-016-0663-7. PMID: 27552848
  • Weaver D, Pohlmann-Eden B. Pharmacoresistant epilepsy: unmet needs in solving the puzzle(s). Epilepsia. 2013 May;54 Suppl 2:80-5. doi: 10.1111/epi.12191. PMID: 23646978
  • Pohlmann-Eden B. Conceptual relevance of new-onset epilepsy Epilepsia. 2011 Jul;52 Suppl 4:1-6. doi: 10.1111/j.1528-1167.2011.03142.x. PMID: 21732932
  • Pohlmann-Eden B. Newton M. EEG and neuroimaging following an epileptic seizure. Epilepsia. 2008;49 Suppl 1:19-25. doi: 10.1111/j.1528-1167.2008.01445.x. PMID: 18184150
  • Pohlmann-Eden B, Beghi E, Camfield C, Camfield P. The first seizure and its management in adults and children. BMJ. 2006 Feb 11;332(7537):339-42. PMID: 16470055

Research interests

Dr. Bernd Pohlmann-Eden is a neurologist and world-renowned expert in epilepsy with a research focus on early stages of epilepsy, prospective cohort studies, mechanisms of pharmacoresistance, aging and epilepsy. He questions current brain disease concepts with disease entities. He rather suggests the perspective of brain network disorders with diverse expressions of symptoms. He considers the separation of neurological diseases from mental health diseases too be outdated. He has a strong interest in mindfulness in medicine. His ultimate interest is to:

  • improve understanding of brain diseases
  • contribute to the best possible care for patients
  • make the patient the expert (knowledge transfer),
  • optimize health care portals with fast and efficient access to up-to-date diagnostic and treatment strategies
  • reduce harm or deterioration of diseases by improving timing and safety of medical interventions

Employment

  • Dalhousie University, Halifax: Health Care Program development & First seizure studies (2017–present)
  • Professor of Neurology, Department of Medicine, Co-Director Epilepsy Program, Director Epilepsy Program Development, Dalhousie University, Halifax, Canada (2008–2016)
  • Head and Chair Epilepsy Centre Bethel, Bielefeld, Germany, Germany Scientific Head of Society for Epilepsy Research in Bethel (2003–2007)
  • Professor of Neurology, Director Epilepsy Program, Mannheim Hospital, University of Heidelberg, Germany (1995–2002)
  • Department of Neurology, Mannheim Hospital, University of Heidelberg, Germany (1981–2002)

Teaching